"Antimalarials" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
| Descriptor ID |
D000962
|
| MeSH Number(s) |
D27.505.954.122.250.100.085
|
| Concept/Terms |
Antimalarials- Antimalarials
- Antimalarial Agents
- Agents, Antimalarial
- Antimalarial Drugs
- Drugs, Antimalarial
- Anti-Malarials
- Anti Malarials
|
Below are MeSH descriptors whose meaning is more general than "Antimalarials".
Below are MeSH descriptors whose meaning is more specific than "Antimalarials".
This graph shows the total number of publications written about "Antimalarials" by people in this website by year, and whether "Antimalarials" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 4 | 0 | 4 |
| 2004 | 4 | 1 | 5 |
| 2005 | 3 | 0 | 3 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 4 | 0 | 4 |
| 2011 | 0 | 1 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 2 | 3 |
| 2014 | 5 | 0 | 5 |
| 2015 | 4 | 1 | 5 |
| 2016 | 2 | 5 | 7 |
| 2017 | 59 | 26 | 85 |
| 2018 | 53 | 26 | 79 |
| 2019 | 20 | 7 | 27 |
| 2020 | 36 | 58 | 94 |
| 2021 | 7 | 20 | 27 |
To return to the timeline, click here.
Below are the most recent publications written about "Antimalarials" by people in Profiles.
-
Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19 Turk J Med Sci. 2021 12 13; 51(6):2827-2834.
-
The impact of COVID-19 on antimalarial supply chains in Ghana. Lancet Glob Health. 2021 09; 9(9):e1208.
-
Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19. Am J Med. 2022 01; 135(1):7-9.
-
Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. Int J Mol Sci. 2021 Aug 12; 22(16).
-
Connected diagnostics to improve accurate diagnosis, treatment, and conditional payment of malaria services in Kenya. BMC Med Inform Decis Mak. 2021 08 04; 21(1):233.
-
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials. Expert Rev Anti Infect Ther. 2021 Oct; 19(10):1219-1244.
-
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies. Biomolecules. 2021 07 06; 11(7).
-
Challenges with the proposed approach in enhancing the accessibility of antimalarial activities during COVID 19 pandemic. J Infect Public Health. 2021 Aug; 14(8):1089-1094.
-
Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic. Clin Rheumatol. 2022 Jan; 41(1):1-18.
-
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues. Antiviral Res. 2021 09; 193:105127.